InnoCare Pharma Ltd

Common Name
InnoCare Pharma
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
1,089
Ticker
688428
Exchange
SHANGHAI STOCK EXCHANGE
Description
InnoCare Pharma Ltd. is a biopharmaceutical company engaged in the discovery, development, and commercialization of innovative treatments for diseases with substantial unmet clinical needs. Focused pr...

InnoCare Pharma Waste Data Preview

In 2023, InnoCare Pharma conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.

Metric (tonnes)2024202320222021 - 2017
Total Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Waste Recovered
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Hazardous Waste Generated
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Non-Hazardous Waste Disposed
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.

Insights into InnoCare Pharma’s Generation of Hazardous and Non-Hazardous Waste

In 2023, InnoCare Pharma generated a total of 1,419 metric tonnes of waste.

Of this amount, 16.13% of InnoCare Pharma's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 83.87% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.

InnoCare Pharma’s Hazardous vs Non-Hazardous Waste Over Time

20212022202307501.5 k2.25 k3 ktonnes
  • Total Non-Hazardous Waste Generated
  • Total Hazardous Waste Generated

How InnoCare Pharma reduced the environmental impact of its waste?

Since 2021, InnoCare Pharma's total waste generation fell by 52.41%, but rose by 19.31% in 2023 , potentially reflecting a temporary surge in activity or inconsistency in waste control strategies.

Over the same period, the share of hazardous waste in InnoCare Pharma's total output increased by 350.21%, including a further 66.68% rise in 2023, suggesting a troubling upward shift toward more environmentally harmful waste streams that could raise compliance costs and environmental risks.

Overall, InnoCare Pharma had previously reduced its waste generation, but recent increases in both volume and hazardousness suggest potential reversals or emerging operational risks that warrant further investigation.

Want Full Access to InnoCare Pharma's Waste Management Dataset?
Sign Up